News › Politics
FDA adds warning label to GLP-1 obesity drugs over rare vision-loss condition
First reported Nov 9, 12:42 PM ET · 8 articles from 7 outlets
Who covered it
2 of the 32 left-leaning outlets we read (6%) · 4 of 31 center (13%) · 1 of 31 right-leaning (3%)
Who reported it first
Nov 9, 12:42 PM ETLeft
Nov 9, 3:27 PM ETLeft
Nov 9, 4:07 PM ETCenter
Nov 9, 4:21 PM ETCenter
Nov 9, 7:30 PM ETRight
Coverage
Left · 2
FDA adds warning label to obesity drugs for eye condition
FDA adds rare vision-loss warning to popular GLP-1 drugs
Center · 5
FDA adds rare vision-loss warning to popular GLP-1 drugs
FDA adds rare vision-loss warning to popular GLP-1 drugs
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
FDA warns of rare vision-loss side effect from GLP-1 drugs
FDA tells GLP-1 makers to warn of potential vision loss side effect
Headlines link to each outlet's own article. Lean is from published research on each outlet's audience (Robertson et al., 2018), not our judgment of its content. Stories are grouped automatically from 100 outlets' public feeds. Method